DHL Supply Chain Invests $150 Million to Expand Pharmaceutical and Medical Device Distribution Network in the U.S. – PRweb.com

“DHL Supply Chain, the Americas leader in contract logistics and part of Deutsche Post DHL Group, is expanding its pharmaceutical and medical device distribution network by 40 percent this year with an investment of $150 million. With the ultimate goal of bringing critical healthcare products closer to trade partners and patients, DHL Supply Chain plans for nine new sites by the end of 2019. The investment includes costs to invest in new buildings and technology, as well as the fit-out and start-up of new or expanded operations.”

Read the full source article:  DHL Supply Chain Invests $150 Million to Expand Pharmaceutical and Medical Device Distribution Network in the U.S. – PRweb.com


#CaliforniaDesignatedRepresentative #CaliforniaDesRep

Go to DREprof.com: The Designated Representative and Exemptee Training Website

Theft and Sabotage in the Supply Chain is Big Business – HealthcarePackaging.com

“Supply chain theft is estimated at $35-40 billion per year in the US, and today’s threats to the commercial supply chain are different than those of the past. Logistics companies are perfect targets, and those that aren’t aware of the changes are more likely to fall prey.”

“Brandman discussed why theft-related loss is getting worse, and said that the value of the product plus a low risk factor, lax security and an inadequate criminal justice system equals high gain, low risk. Plus, says Brandman, the internet combined with small parcel delivery service make it easy to distribute stolen goods. Thieves – often internal – who work together can result in significant loss to the company.”

Read the full article:  Theft and Sabotage in the Supply Chain is Big Business – HealthcarePackaging.com


Go to DREprof.com: The Designated Representative and Exemptee Training Website

The Growing Trend of PBM Track-And-Trace Audits – Frier Levitt

The Growing Trend of PBM Track-And-Trace Audits – Frier Levitt

“Pharmacies are being asked [to] provide transaction history, transaction information, and transaction statement, and to maintain such records for not less than six years after the transaction.”

“Pharmacies are expected to ensure that wholesalers provide the aforementioned information at the time of purchase or be in a position to provide this information at the time of a request. Such requests are being made despite pharmacies having purchased from duly, licensed, and verifiable wholesalers.”

Read the full source article:  The Growing Trend of PBM Track-And-Trace Audits – Frier Levitt


Go to DREprof.com: The Designated Representative and Exemptee Training Website

California Designated Representative Training Online – Available 24 x 7

There’s No Need To Wait!  – –  Take Our California Designated Representative Training Courses  – –  24 x 7 Convenience!

Here’s why you should take California Designated Representative training courses by SkillsPlus International Inc.:

  • We offer the largest selection of courses approved by the California Board of Pharmacy (wholesaler, 3PL, and reverse distributor). Earns you a training affidavit.
  • You don’t have to wait to take a seminar. Simply buy an online course, then enter our online classroom. Come and go at your convenience.
  • We’ve got experience. Since 2002, we’ve trained nearly 6,000 students in our Designated Representative and Exemptee courses.

Go to DREprof.com: The Designated Representative and Exemptee Training Website

McKesson announces Hammergen’s retirement, chooses successor – Drug Store News



“McKesson has announced the retirement of its chairman and CEO John Hammergen, effective March 31, 2019. The company’s board has unanimously elected Brian Tyler, who currently is president and COO of the San Francisco-based company, to succeed him as CEO, effective April 1, 2019. Edward Mueller, McKesson’s lead independent director, will become chairman, also effective April 1, 2019.”

Read the full source article: McKesson announces Hammergen’s retirement, chooses successor – Drug Store News


Go to DREprof.com: The Designated Representative and Exemptee Training Website

License Details About California Designated Representative | mySkills myFuture


What is a California Designated Representative?

“A designated representative is an individual who performs clerical, inventory control, housekeeping, delivery, maintenance, or similar functions related to the distribution or dispensing of dangerous drugs or dangerous devices. To work as a designated representative, you must possess and keep a current certificate as a designated representative.”

Read more, learn more from the source article: License details about Designated Representative | mySkills myFuture | CareerOneStop


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Verify Wholesale Drug Distributor Licenses – FDA.gov



In the course of your work, you might have a need to verify a wholesaler’s license.  Read on.

“Prescription drugs should only be purchased from wholesale drug distributors licensed in the United States. To verify a wholesale drug distributor is licensed in the state(s) where it is conducting business, use the link provided in the table below to access your state licensing authority’s database or contact information. (Note: The databases accessible through the links below are maintained by your state licensing authority.)

U.S. State Agencies Responsible for Licensing Wholesale Prescription Drug Distributors … “

View the entire web page to access the state agency links: Drug Supply Chain Integrity > Verify Wholesale Drug Distributor Licenses – FDA.gov


Go to DREprof.com: The Designated Representative and Exemptee Training Website

How DSCSA Changes the Licensing Landscape | Pharmaceutical Executive


California Designated Representative Training Course for 3PL (approved by the California State Board of Pharmacy)


The impact of new 3PL licensing

The big license aftershock following the DSCSA earthquake came when the FDA redefined the parameters of 3PL companies. Before the passage of DSCSA, 3PL companies could be licensed as a wholesaler. Now, that’s no longer the case.”

Read the entire article to learn how the DSCSA impacts third-party logistics providers (3PLs).

Read the complete article (source): How DSCSA Changes the Licensing Landscape | Pharmaceutical Executive


Go to DREprof.com: The Designated Representative and Exemptee Training Website

TraceLink Bags $93M, Plans A.I. & Blockchain Tools for Drug Tracking – Xconomy

“Another area of interest for TraceLink is blockchains, the online, distributed ledger systems that power cryptocurrencies such as Bitcoin. TraceLink is developing blockchain-based software to help the pharma industry meet certain track and trace requirements in the U.S. Drug Supply Chain Security Act, Dahod says. He says the company will release more details about the project by the end of the year.”

Read the full source article: Xconomy: TraceLink Bags $93M, Plans A.I. & Blockchain Tools for Drug Tracking


Go to DREprof.com: The Designated Representative and Exemptee Training Website


Wholesalers are asked to report key details on suspicious orders of controlled substances – The Script

Go to the full article:
Wholesalers are asked to report key details on suspicious orders of controlled substances – The Script July 2018 p. 13 (a publication of the California State Board of Pharmacy)

“A wholesaler, upon discovery, shall notify the board in writing of any suspicious orders of controlled substances placed by a California-licensed pharmacy or wholesaler by providing the board a copy of the information that the wholesaler provides to the United States Drug Enforcement Administration.  Suspicious orders include, but are not limited to, orders of unusual size, orders deviating substantially from a normal pattern, and orders of unusual frequency.”

The Board requests, ” . . . that reports include explicit information as to why the wholesaler deemed the order suspicious. For example, indicate if (1) the order was of an unusual size, (2) the order deviated substantially from the normal pattern, or (3) the order was of an unusual frequency.”

Reference:   On Oct.
7, 2017, Governor Brown signed
into law Assembly Bill 401.
This bill added Business and
Professions Code section 4169.1


Go to DREprof.com: The Designated Representative and Exemptee Training Website